Coherus Oncology, Inc. Effective Tax Rate
Coherus Oncology, Inc. (CHRS) reported Effective Tax Rate of 0.20% for the 12-month period ending 2023-12-31, per its 8-K filed 2025-11-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2025-11-13
- Coherus Oncology, Inc. effective income tax rate reconciliation, percent for fiscal 2021 was 0.00%, a 100.00% decline from fiscal 2020.
- Coherus Oncology, Inc. effective income tax rate reconciliation, percent for fiscal 2020 was 2.60%, a 18.75% decline from fiscal 2019.
- Coherus Oncology, Inc. effective income tax rate reconciliation, percent for fiscal 2019 was 3.20%.
- Coherus Oncology, Inc. effective income tax rate reconciliation, percent for fiscal 2018 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|
| 2023-12-31 | 0.20% 8-K · filed 2025-11-13 | |
| 2021-12-31 | 0.00% 10-K · filed 2022-02-23 | |
| 2020-12-31 | 2.60% 10-K · filed 2023-03-06 | 2.55% 10-K · filed 2021-02-25 |
| 2019-12-31 | 3.20% 10-K · filed 2022-02-23 | 3.17% 10-K · filed 2020-02-27 |
| 2018-12-31 | 0.00% 10-K · filed 2020-02-27 | |
| 2017-12-31 | 0.00% 10-K · filed 2020-02-27 | |
| 2016-12-31 | 0.00% 10-K · filed 2019-02-28 | |
| 2015-12-31 | 0.00% 10-K · filed 2018-03-08 | |
| 2014-12-31 | 0.00% 10-K · filed 2017-03-14 | |
| 2013-12-31 | 0.00% 10-K · filed 2016-02-29 | |
| 2012-12-31 | 0.00% 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |